[1] 李春英,高天文白癜风相关的黑素细胞抗原.国外医学皮肤性病学分册,2000,26:75-78. [2] 中国中西医结合学会皮肤性病专业委员会色素病学组白癜风临床分型及疗效标准(2003年修订稿).中华皮肤科杂志,2004,37:440. [3] 许爱娥,尉晓冬,毕志刚,等.黑素生成素对黑素细胞增殖和黑素合成作用的研究.中华皮肤科杂志,1997,30:18-23 [4] Song YH, Connor E, Li Y, et al. The role of tyrosinase in autoimmune vitiligo. Lancet, 1994, 344:1049-1052. [5] Baharav E, Merimski O, Shoenfeld Y, et al. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol, 1996, 105:84-88. [6] Fishman P, Merimski O, Baharav E, et al. Autoantibodies to tyrosinase:the bridge between melanoma and vitiligo. Cancer, 1997, 79:1461-1464. [7] McHale JF, Harari OA, Marshall D, et al. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J hnmunol, 1999, 163:3993-4000. [8] al Badri AM, Foulis AK, Todd PM, et al. Abnormal expression of MHC class Ⅱ and ICAM-1 by melanocytes in vitiligo. J Pathol,1993, 169:203-206. [9] Hwang JH, Ahn JS, Kim SD, et al. The changes of serum soluble intercellular adhesion molecule-1 after systemic steroid treatment in vitiligo. J Dermatol Sci, 1999, 22:11-16. |